Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition
Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1665-1669
DOI: 10.1200/jco-25-03121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Linda D Bosserman und 1 weiteren Autor:innen. Beteiligte Einrichtung: City of Hope, Duarte, CA. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- City of Hope, Duarte, CA.
- Tufts Medicine, Tufts Medical Center, and Tufts University School of Medicine, Boston, MA.
ORCID-Profile: Linda D Bosserman, Don S Dizon
Zitieren
APA
Bosserman, L. D., & Dizon, D. S. (2026). Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition. Journal of Clinical Oncology, 44(18), 1665-1669. https://doi.org/10.1200/jco-25-03121
Vancouver
Bosserman LD, Dizon DS. Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition. Journal of Clinical Oncology. 2026;44(18):1665-1669. doi:10.1200/jco-25-03121
BibTeX
@article{Bosserman2026,
author = {Bosserman, Linda D and Dizon, Don S},
title = {Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {18},
pages = {1665--1669},
doi = {10.1200/jco-25-03121}
}
EUVIMED